The Pennant Group, Inc. (PNTG) 10-Year Financial Performance & Capital Metrics

PNTG • • Industrial / General

HealthcareHealthcare FacilitiesHome Health & Hospice CareComprehensive Home Health Providers

AboutThe Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.Show more

Revenue $695M +27.6%
EBITDA $44M +46.0%
Net Income $23M +68.6%
EPS (Diluted) 0.71 +61.4%
Gross Margin 13.49% +9.6%
EBITDA Margin 6.36% +14.4%
Operating Margin 5.48% +18.7%
Net Margin 3.24% +32.1%
ROE 9.86%
ROIC 5.55% +35.2%
Debt/Equity 0.88 -61.4%
Interest Coverage 5.48 +29.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 54.7%
✓Strong Piotroski F-Score: 8/9
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 15.5%
✓Trading near 52-week high
✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y15.48%

3Y16.5%

TTM29.89%

Profit (Net Income) CAGR

10Y-

5Y54.7%

3Y103.02%

TTM26.24%

EPS CAGR

10Y-

5Y52.53%

3Y116.36%

TTM10.29%

ROCE

10Y Avg10.03%

5Y Avg4.27%

3Y Avg5.22%

Latest7.29%

Peer Comparison

Comprehensive Home Health Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.03B	29.90	42.11	27.59%	3.15%	7.78%	2.93%	0.88
CHEChemed Corporation	6.48B	458.93	23.07	7.37%	11.02%	25.89%	5.68%	0.13
EHABEnhabit, Inc.	551.11M	10.89	-3.50	-1.1%	-1.14%	-1.99%	8.6%	1.03
AVAHAveanna Healthcare Holdings Inc.	2.04B	9.76	-172.13	6.82%	0.85%		1.29%

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	250.99M	286.06M	338.53M	390.95M	439.69M	473.24M	544.89M	695.24M
Revenue Growth %	-	0.14%	0.18%	0.15%	0.12%	0.08%	0.15%	0.28%
Cost of Goods Sold+	218.58M	243.62M	293.92M	336.06M	391.1M	414.66M	477.86M	601.48M
COGS % of Revenue	0.87%	0.85%	0.87%	0.86%	0.89%	0.88%	0.88%	0.87%
Gross Profit+	32.41M	42.44M	44.62M	54.89M	48.59M	58.59M	67.04M	93.76M
Gross Margin %	0.13%	0.15%	0.13%	0.14%	0.11%	0.12%	0.12%	0.13%
Gross Profit Growth %	-	0.31%	0.05%	0.23%	-0.11%	0.21%	0.14%	0.4%
Operating Expenses+	17.01M	21.81M	38.95M	35.97M	43.9M	45.85M	41.87M	55.65M
OpEx % of Revenue	0.07%	0.08%	0.12%	0.09%	0.1%	0.1%	0.08%	0.08%
Selling, General & Admin	14.46M	18.84M	35.13M	31.3M	36.26M	33.98M	36.67M	50.21M
SG&A % of Revenue	0.06%	0.07%	0.1%	0.08%	0.08%	0.07%	0.07%	0.07%
Research & Development	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-
Other Operating Expenses	2.54M	2.96M	3.81M	4.67M	7.64M	11.87M	5.2M	5.44M
Operating Income+	15.4M	20.63M	5.67M	18.92M	4.7M	12.74M	25.17M	38.12M
Operating Margin %	0.06%	0.07%	0.02%	0.05%	0.01%	0.03%	0.05%	0.05%
Operating Income Growth %	-	0.34%	-0.73%	2.34%	-0.75%	1.71%	0.98%	0.51%
EBITDA+	17.95M	23.59M	9.48M	23.59M	9.48M	17.64M	30.3M	44.23M
EBITDA Margin %	0.07%	0.08%	0.03%	0.06%	0.02%	0.04%	0.06%	0.06%
EBITDA Growth %	-	0.31%	-0.6%	1.49%	-0.6%	0.86%	0.72%	0.46%
D&A (Non-Cash Add-back)	2.54M	2.96M	3.81M	4.67M	4.78M	4.9M	5.13M	6.12M
EBIT	15.4M	20.63M	5.67M	19.14M	4.67M	12.71M	25.51M	38.32M
Net Interest Income+	0	0	-410K	-1.24M	-1.94M	-3.82M	-5.92M	-6.96M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	0	0	410K	1.24M	1.94M	3.82M	5.92M	6.96M
Other Income/Expense	0	0	-410K	-1.01M	-1.97M	-3.85M	-5.58M	-6.75M
Pretax Income+	15.4M	20.63M	5.26M	17.9M	2.73M	8.89M	19.58M	31.37M
Pretax Margin %	0.06%	0.07%	0.02%	0.05%	0.01%	0.02%	0.04%	0.05%
Income Tax+	5.38M	4.35M	2.08M	2.35M	582K	1.65M	5.67M	7.03M
Effective Tax Rate %	0.64%	0.76%	0.48%	0.88%	0.99%	0.75%	0.68%	0.72%
Net Income+	9.87M	15.68M	2.55M	15.74M	2.7M	6.64M	13.38M	22.56M
Net Margin %	0.04%	0.05%	0.01%	0.04%	0.01%	0.01%	0.02%	0.03%
Net Income Growth %	-	0.59%	-0.84%	5.18%	-0.83%	1.46%	1.01%	0.69%
Net Income (Continuing)	10.03M	16.28M	3.17M	15.55M	2.15M	7.24M	13.91M	24.34M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	4.92M	9.43M	0	4.59M	4.04M	4.64M	5.18M	18.68M
EPS (Diluted)+	0.35	0.56	0.09	0.52	0.07	0.22	0.44	0.71
EPS Growth %	-	0.6%	-0.85%	5.05%	-0.87%	2.14%	1%	0.61%
EPS (Basic)	0.35	0.56	0.09	0.56	0.08	0.23	0.45	0.72
Diluted Shares Outstanding	28M	28M	29.59M	30.23M	30.64M	30.16M	30.19M	32M
Basic Shares Outstanding	27.83M	27.83M	27.84M	28.03M	28.41M	29.06M	29.86M	31.19M
Dividend Payout Ratio	-	-	4.56%	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	26.7M	29.12M	38.68M	59.6M	75.84M	73.82M	80.08M	122.86M
Cash & Short-Term Investments	36K	41K	402K	43K	5.19M	2.08M	6.06M	24.25M
Cash Only	36K	41K	402K	43K	5.19M	2.08M	6.06M	24.25M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	22.25M	24.47M	32.18M	47.22M	53.94M	53.42M	61.12M	81.3M
Days Sales Outstanding	32.35	31.22	34.7	44.09	44.78	41.2	40.94	42.68
Inventory	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-
Other Current Assets	0	0	0	0	16.71M	18.32M	12.9M	17.31M
Total Non-Current Assets+	61.59M	69.03M	409.07M	447.38M	454.46M	438.3M	459.61M	556.66M
Property, Plant & Equipment	8.79M	10.46M	330.97M	326.53M	317.79M	287.49M	291.52M	313.88M
Fixed Asset Turnover	28.54x	27.35x	1.02x	1.20x	1.38x	1.65x	1.87x	2.21x
Goodwill	27.96M	30.89M	41.23M	66.44M	74.27M	79.5M	91.01M	129.12M
Intangible Assets	22.88M	25.21M	33.46M	47.49M	53.73M	58.62M	67.74M	96.18M
Long-Term Investments	0	0	0	0	0	0	0	0
Other Non-Current Assets	1.95M	2.46M	3.4M	4.81M	4.83M	10.54M	9.34M	17.48M
Total Assets+	88.29M	98.15M	447.75M	506.98M	530.3M	512.12M	539.69M	679.52M
Asset Turnover	2.84x	2.91x	0.76x	0.77x	0.83x	0.92x	1.01x	1.02x
Asset Growth %	-	0.11%	3.56%	0.13%	0.05%	-0.03%	0.05%	0.26%
Total Current Liabilities+	26.25M	29.55M	51.19M	89.02M	71.64M	70.25M	71.55M	101.7M
Accounts Payable	3.08M	4.39M	8.65M	9.76M	10.55M	13.65M	10.84M	18.74M
Days Payables Outstanding	5.14	6.58	10.75	10.6	9.85	12.01	8.28	11.37
Short-Term Debt	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	-1.31M	10.83M	0	0	13.82M	1.48M	13.67M	705K
Current Ratio	1.02x	0.99x	0.76x	0.67x	1.06x	1.05x	1.12x	1.21x
Quick Ratio	1.02x	0.99x	0.76x	0.67x	1.06x	1.05x	1.12x	1.21x
Cash Conversion Cycle	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	2.12M	3.32M	325.45M	316.79M	344.42M	316.21M	322.63M	265.86M
Long-Term Debt	0	0	18.53M	8.28M	51.37M	62.89M	63.91M	0
Capital Lease Obligations	0	0	304.04M	296.62M	287.75M	247.04M	248.6M	253.42M
Deferred Tax Liabilities	0	0	0	0	88.21M	0	1.85M	1.86M
Other Non-Current Liabilities	2.12M	3.32M	2.88M	11.9M	5.29M	6.28M	8.26M	10.57M
Total Liabilities	28.37M	32.86M	376.64M	405.8M	416.05M	386.46M	394.18M	367.56M
Total Debt+	0	0	334.86M	319M	355.24M	326.57M	329.63M	273.09M
Net Debt	-36K	-41K	334.45M	318.95M	350.05M	324.49M	323.57M	248.84M
Debt / Equity	-	-	4.71x	3.15x	3.11x	2.60x	2.27x	0.88x
Debt / EBITDA	-	-	35.32x	13.52x	37.48x	18.51x	10.88x	6.17x
Net Debt / EBITDA	-0.00x	-0.00x	35.28x	13.52x	36.93x	18.40x	10.68x	5.63x
Interest Coverage	-	-	13.83x	15.27x	2.42x	3.34x	4.25x	5.48x
Total Equity+	59.92M	65.29M	71.11M	101.17M	114.24M	125.66M	145.51M	311.96M
Equity Growth %	-	0.09%	0.09%	0.42%	0.13%	0.1%	0.16%	1.14%
Book Value per Share	2.14	2.33	2.40	3.35	3.73	4.17	4.82	9.75
Total Shareholders' Equity	55M	55.86M	71.11M	96.58M	110.2M	121.01M	140.34M	293.28M
Common Stock	55M	55.86M	28K	28K	28K	29K	29K	35K
Retained Earnings	0	0	-3.8M	11.95M	14.64M	21.28M	34.66M	57.22M
Treasury Stock	0	0	0	-65K	-65K	-65K	-65K	-65K
Accumulated OCI	0	0	0	0	0	0	0	0
Minority Interest	4.92M	9.43M	0	4.59M	4.04M	4.64M	5.18M	18.68M

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	17.25M	23.27M	9.55M	50.2M	-18.22M	9.04M	33.09M	39.3M
Operating CF Margin %	0.07%	0.08%	0.03%	0.13%	-0.04%	0.02%	0.06%	0.06%
Operating CF Growth %	-	0.35%	-0.59%	4.25%	-1.36%	1.5%	2.66%	0.19%
Net Income	10.03M	16.28M	3.17M	15.55M	2.15M	7.24M	13.91M	24.34M
Depreciation & Amortization	2.54M	2.96M	3.81M	4.67M	4.78M	4.9M	5.13M	6.12M
Stock-Based Compensation	2.3M	2.38M	3.38M	8.34M	10.04M	3.09M	5.37M	7.78M
Deferred Taxes	-160K	-595K	79K	-2.2M	-1.75M	1.7M	4M	-1.19M
Other Non-Cash Items	3.53M	941K	1.16M	890K	3.94M	1.62M	1.24M	1.32M
Working Capital Changes	-993K	1.3M	-2.05M	22.95M	-37.38M	-9.5M	3.44M	929K
Change in Receivables	-5.71M	-2.57M	-8.57M	-15.71M	-7.33M	-361K	-7.35M	-21.09M
Change in Inventory	3.02M	1.77M	269K	9.67M	0	0	0	0
Change in Payables	432K	1.37M	4.07M	993K	562K	2.37M	-1.84M	8.05M
Cash from Investing+	-16.08M	-9.48M	-26.46M	-41.62M	-20.12M	-24.24M	-30.22M	-70.68M
Capital Expenditures	-3.13M	-3.6M	-6.71M	-7.25M	-6.3M	-14.17M	-8.11M	-8.99M
CapEx % of Revenue	0.01%	0.01%	0.02%	0.02%	0.01%	0.03%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-891K	-1.15M	-991K	-1.17M	-267K	61K	-741K	-13.28M
Cash from Financing+	-1.16M	-13.79M	17.27M	-8.95M	43.49M	12.08M	1.11M	49.57M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	-11.6M	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-1.16M	-13.79M	8.87M	1.62M	-510K	0	33K	-4.43M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	14.12M	19.67M	2.84M	42.95M	-24.53M	-5.13M	24.98M	30.31M
FCF Margin %	0.06%	0.07%	0.01%	0.11%	-0.06%	-0.01%	0.05%	0.04%
FCF Growth %	-	0.39%	-0.86%	14.12%	-1.57%	0.79%	5.87%	0.21%
FCF per Share	0.50	0.70	0.10	1.42	-0.80	-0.17	0.83	0.95
FCF Conversion (FCF/Net Income)	1.75x	1.48x	3.75x	3.19x	-6.76x	1.36x	2.47x	1.74x
Interest Paid	0	0	156K	1.12M	1.45M	3.03M	5.01M	6.52M
Taxes Paid	0	0	120K	7.87M	2.62M	99K	841K	7.35M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	16.47%	25.05%	3.73%	18.28%	2.5%	5.54%	9.87%	9.86%
Return on Invested Capital (ROIC)	19.29%	24.73%	1.81%	3.44%	0.8%	2.09%	4.11%	5.55%
Gross Margin	12.91%	14.84%	13.18%	14.04%	11.05%	12.38%	12.3%	13.49%
Net Margin	3.93%	5.48%	0.75%	4.03%	0.61%	1.4%	2.46%	3.24%
Debt / Equity	-	-	4.71x	3.15x	3.11x	2.60x	2.27x	0.88x
Interest Coverage	-	-	13.83x	15.27x	2.42x	3.34x	4.25x	5.48x
FCF Conversion	1.75x	1.48x	3.75x	3.19x	-6.76x	1.36x	2.47x	1.74x
Revenue Growth	-	13.97%	18.34%	15.49%	12.47%	7.63%	15.14%	27.59%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Home Health And Hospice Services	206.62M	253.66M	309.57M	342.25M	394.46M	515.34M
Home Health And Hospice Services Growth	-	22.76%	22.04%	10.56%	15.26%	30.64%
Senior Living Services	131.91M	137.29M	130.12M	130.99M	150.43M	175.76M
Senior Living Services Growth	-	4.08%	-5.22%	0.67%	14.84%	16.84%

Frequently Asked Questions

Valuation & Price

The Pennant Group, Inc. (PNTG) has a price-to-earnings (P/E) ratio of 42.1x. This suggests investors expect higher future growth.

Growth & Financials

The Pennant Group, Inc. (PNTG) reported $847.3M in revenue for fiscal year 2024. This represents a 238% increase from $251.0M in 2017.

The Pennant Group, Inc. (PNTG) grew revenue by 27.6% over the past year. This is strong growth.

Yes, The Pennant Group, Inc. (PNTG) is profitable, generating $26.7M in net income for fiscal year 2024 (3.2% net margin).

Dividend & Returns

The Pennant Group, Inc. (PNTG) has a return on equity (ROE) of 9.9%. This is below average, suggesting room for improvement.

The Pennant Group, Inc. (PNTG) generated $36.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

The Pennant Group, Inc. (PNTG) 10-Year Financial Performance & Capital Metrics

PNTG • • Industrial / General

HealthcareHealthcare FacilitiesHome Health & Hospice CareComprehensive Home Health Providers

Revenue $695M +27.6%
EBITDA $44M +46.0%
Net Income $23M +68.6%
EPS (Diluted) 0.71 +61.4%
Gross Margin 13.49% +9.6%
EBITDA Margin 6.36% +14.4%
Operating Margin 5.48% +18.7%
Net Margin 3.24% +32.1%
ROE 9.86%
ROIC 5.55% +35.2%
Debt/Equity 0.88 -61.4%
Interest Coverage 5.48 +29.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 54.7%
✓Strong Piotroski F-Score: 8/9
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 15.5%
✓Trading near 52-week high
✓Efficient asset utilization: 1.0x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y15.48%

3Y16.5%

TTM29.89%

Profit (Net Income) CAGR

10Y-

5Y54.7%

3Y103.02%

TTM26.24%

EPS CAGR

10Y-

5Y52.53%

3Y116.36%

TTM10.29%

ROCE

10Y Avg10.03%

5Y Avg4.27%

3Y Avg5.22%

Latest7.29%

Peer Comparison

Comprehensive Home Health Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.03B	29.90	42.11	27.59%	3.15%	7.78%	2.93%	0.88
CHEChemed Corporation	6.48B	458.93	23.07	7.37%	11.02%	25.89%	5.68%	0.13
EHABEnhabit, Inc.	551.11M	10.89	-3.50	-1.1%	-1.14%	-1.99%	8.6%	1.03
AVAHAveanna Healthcare Holdings Inc.	2.04B	9.76	-172.13	6.82%	0.85%		1.29%

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	250.99M	286.06M	338.53M	390.95M	439.69M	473.24M	544.89M	695.24M
Revenue Growth %	-	0.14%	0.18%	0.15%	0.12%	0.08%	0.15%	0.28%
Cost of Goods Sold+	218.58M	243.62M	293.92M	336.06M	391.1M	414.66M	477.86M	601.48M
COGS % of Revenue	0.87%	0.85%	0.87%	0.86%	0.89%	0.88%	0.88%	0.87%
Gross Profit+	32.41M	42.44M	44.62M	54.89M	48.59M	58.59M	67.04M	93.76M
Gross Margin %	0.13%	0.15%	0.13%	0.14%	0.11%	0.12%	0.12%	0.13%
Gross Profit Growth %	-	0.31%	0.05%	0.23%	-0.11%	0.21%	0.14%	0.4%
Operating Expenses+	17.01M	21.81M	38.95M	35.97M	43.9M	45.85M	41.87M	55.65M
OpEx % of Revenue	0.07%	0.08%	0.12%	0.09%	0.1%	0.1%	0.08%	0.08%
Selling, General & Admin	14.46M	18.84M	35.13M	31.3M	36.26M	33.98M	36.67M	50.21M
SG&A % of Revenue	0.06%	0.07%	0.1%	0.08%	0.08%	0.07%	0.07%	0.07%
Research & Development	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-
Other Operating Expenses	2.54M	2.96M	3.81M	4.67M	7.64M	11.87M	5.2M	5.44M
Operating Income+	15.4M	20.63M	5.67M	18.92M	4.7M	12.74M	25.17M	38.12M
Operating Margin %	0.06%	0.07%	0.02%	0.05%	0.01%	0.03%	0.05%	0.05%
Operating Income Growth %	-	0.34%	-0.73%	2.34%	-0.75%	1.71%	0.98%	0.51%
EBITDA+	17.95M	23.59M	9.48M	23.59M	9.48M	17.64M	30.3M	44.23M
EBITDA Margin %	0.07%	0.08%	0.03%	0.06%	0.02%	0.04%	0.06%	0.06%
EBITDA Growth %	-	0.31%	-0.6%	1.49%	-0.6%	0.86%	0.72%	0.46%
D&A (Non-Cash Add-back)	2.54M	2.96M	3.81M	4.67M	4.78M	4.9M	5.13M	6.12M
EBIT	15.4M	20.63M	5.67M	19.14M	4.67M	12.71M	25.51M	38.32M
Net Interest Income+	0	0	-410K	-1.24M	-1.94M	-3.82M	-5.92M	-6.96M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	0	0	410K	1.24M	1.94M	3.82M	5.92M	6.96M
Other Income/Expense	0	0	-410K	-1.01M	-1.97M	-3.85M	-5.58M	-6.75M
Pretax Income+	15.4M	20.63M	5.26M	17.9M	2.73M	8.89M	19.58M	31.37M
Pretax Margin %	0.06%	0.07%	0.02%	0.05%	0.01%	0.02%	0.04%	0.05%
Income Tax+	5.38M	4.35M	2.08M	2.35M	582K	1.65M	5.67M	7.03M
Effective Tax Rate %	0.64%	0.76%	0.48%	0.88%	0.99%	0.75%	0.68%	0.72%
Net Income+	9.87M	15.68M	2.55M	15.74M	2.7M	6.64M	13.38M	22.56M
Net Margin %	0.04%	0.05%	0.01%	0.04%	0.01%	0.01%	0.02%	0.03%
Net Income Growth %	-	0.59%	-0.84%	5.18%	-0.83%	1.46%	1.01%	0.69%
Net Income (Continuing)	10.03M	16.28M	3.17M	15.55M	2.15M	7.24M	13.91M	24.34M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	4.92M	9.43M	0	4.59M	4.04M	4.64M	5.18M	18.68M
EPS (Diluted)+	0.35	0.56	0.09	0.52	0.07	0.22	0.44	0.71
EPS Growth %	-	0.6%	-0.85%	5.05%	-0.87%	2.14%	1%	0.61%
EPS (Basic)	0.35	0.56	0.09	0.56	0.08	0.23	0.45	0.72
Diluted Shares Outstanding	28M	28M	29.59M	30.23M	30.64M	30.16M	30.19M	32M
Basic Shares Outstanding	27.83M	27.83M	27.84M	28.03M	28.41M	29.06M	29.86M	31.19M
Dividend Payout Ratio	-	-	4.56%	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	26.7M	29.12M	38.68M	59.6M	75.84M	73.82M	80.08M	122.86M
Cash & Short-Term Investments	36K	41K	402K	43K	5.19M	2.08M	6.06M	24.25M
Cash Only	36K	41K	402K	43K	5.19M	2.08M	6.06M	24.25M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	22.25M	24.47M	32.18M	47.22M	53.94M	53.42M	61.12M	81.3M
Days Sales Outstanding	32.35	31.22	34.7	44.09	44.78	41.2	40.94	42.68
Inventory	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-
Other Current Assets	0	0	0	0	16.71M	18.32M	12.9M	17.31M
Total Non-Current Assets+	61.59M	69.03M	409.07M	447.38M	454.46M	438.3M	459.61M	556.66M
Property, Plant & Equipment	8.79M	10.46M	330.97M	326.53M	317.79M	287.49M	291.52M	313.88M
Fixed Asset Turnover	28.54x	27.35x	1.02x	1.20x	1.38x	1.65x	1.87x	2.21x
Goodwill	27.96M	30.89M	41.23M	66.44M	74.27M	79.5M	91.01M	129.12M
Intangible Assets	22.88M	25.21M	33.46M	47.49M	53.73M	58.62M	67.74M	96.18M
Long-Term Investments	0	0	0	0	0	0	0	0
Other Non-Current Assets	1.95M	2.46M	3.4M	4.81M	4.83M	10.54M	9.34M	17.48M
Total Assets+	88.29M	98.15M	447.75M	506.98M	530.3M	512.12M	539.69M	679.52M
Asset Turnover	2.84x	2.91x	0.76x	0.77x	0.83x	0.92x	1.01x	1.02x
Asset Growth %	-	0.11%	3.56%	0.13%	0.05%	-0.03%	0.05%	0.26%
Total Current Liabilities+	26.25M	29.55M	51.19M	89.02M	71.64M	70.25M	71.55M	101.7M
Accounts Payable	3.08M	4.39M	8.65M	9.76M	10.55M	13.65M	10.84M	18.74M
Days Payables Outstanding	5.14	6.58	10.75	10.6	9.85	12.01	8.28	11.37
Short-Term Debt	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	-1.31M	10.83M	0	0	13.82M	1.48M	13.67M	705K
Current Ratio	1.02x	0.99x	0.76x	0.67x	1.06x	1.05x	1.12x	1.21x
Quick Ratio	1.02x	0.99x	0.76x	0.67x	1.06x	1.05x	1.12x	1.21x
Cash Conversion Cycle	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	2.12M	3.32M	325.45M	316.79M	344.42M	316.21M	322.63M	265.86M
Long-Term Debt	0	0	18.53M	8.28M	51.37M	62.89M	63.91M	0
Capital Lease Obligations	0	0	304.04M	296.62M	287.75M	247.04M	248.6M	253.42M
Deferred Tax Liabilities	0	0	0	0	88.21M	0	1.85M	1.86M
Other Non-Current Liabilities	2.12M	3.32M	2.88M	11.9M	5.29M	6.28M	8.26M	10.57M
Total Liabilities	28.37M	32.86M	376.64M	405.8M	416.05M	386.46M	394.18M	367.56M
Total Debt+	0	0	334.86M	319M	355.24M	326.57M	329.63M	273.09M
Net Debt	-36K	-41K	334.45M	318.95M	350.05M	324.49M	323.57M	248.84M
Debt / Equity	-	-	4.71x	3.15x	3.11x	2.60x	2.27x	0.88x
Debt / EBITDA	-	-	35.32x	13.52x	37.48x	18.51x	10.88x	6.17x
Net Debt / EBITDA	-0.00x	-0.00x	35.28x	13.52x	36.93x	18.40x	10.68x	5.63x
Interest Coverage	-	-	13.83x	15.27x	2.42x	3.34x	4.25x	5.48x
Total Equity+	59.92M	65.29M	71.11M	101.17M	114.24M	125.66M	145.51M	311.96M
Equity Growth %	-	0.09%	0.09%	0.42%	0.13%	0.1%	0.16%	1.14%
Book Value per Share	2.14	2.33	2.40	3.35	3.73	4.17	4.82	9.75
Total Shareholders' Equity	55M	55.86M	71.11M	96.58M	110.2M	121.01M	140.34M	293.28M
Common Stock	55M	55.86M	28K	28K	28K	29K	29K	35K
Retained Earnings	0	0	-3.8M	11.95M	14.64M	21.28M	34.66M	57.22M
Treasury Stock	0	0	0	-65K	-65K	-65K	-65K	-65K
Accumulated OCI	0	0	0	0	0	0	0	0
Minority Interest	4.92M	9.43M	0	4.59M	4.04M	4.64M	5.18M	18.68M

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	17.25M	23.27M	9.55M	50.2M	-18.22M	9.04M	33.09M	39.3M
Operating CF Margin %	0.07%	0.08%	0.03%	0.13%	-0.04%	0.02%	0.06%	0.06%
Operating CF Growth %	-	0.35%	-0.59%	4.25%	-1.36%	1.5%	2.66%	0.19%
Net Income	10.03M	16.28M	3.17M	15.55M	2.15M	7.24M	13.91M	24.34M
Depreciation & Amortization	2.54M	2.96M	3.81M	4.67M	4.78M	4.9M	5.13M	6.12M
Stock-Based Compensation	2.3M	2.38M	3.38M	8.34M	10.04M	3.09M	5.37M	7.78M
Deferred Taxes	-160K	-595K	79K	-2.2M	-1.75M	1.7M	4M	-1.19M
Other Non-Cash Items	3.53M	941K	1.16M	890K	3.94M	1.62M	1.24M	1.32M
Working Capital Changes	-993K	1.3M	-2.05M	22.95M	-37.38M	-9.5M	3.44M	929K
Change in Receivables	-5.71M	-2.57M	-8.57M	-15.71M	-7.33M	-361K	-7.35M	-21.09M
Change in Inventory	3.02M	1.77M	269K	9.67M	0	0	0	0
Change in Payables	432K	1.37M	4.07M	993K	562K	2.37M	-1.84M	8.05M
Cash from Investing+	-16.08M	-9.48M	-26.46M	-41.62M	-20.12M	-24.24M	-30.22M	-70.68M
Capital Expenditures	-3.13M	-3.6M	-6.71M	-7.25M	-6.3M	-14.17M	-8.11M	-8.99M
CapEx % of Revenue	0.01%	0.01%	0.02%	0.02%	0.01%	0.03%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	-891K	-1.15M	-991K	-1.17M	-267K	61K	-741K	-13.28M
Cash from Financing+	-1.16M	-13.79M	17.27M	-8.95M	43.49M	12.08M	1.11M	49.57M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	-11.6M	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	-1.16M	-13.79M	8.87M	1.62M	-510K	0	33K	-4.43M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	14.12M	19.67M	2.84M	42.95M	-24.53M	-5.13M	24.98M	30.31M
FCF Margin %	0.06%	0.07%	0.01%	0.11%	-0.06%	-0.01%	0.05%	0.04%
FCF Growth %	-	0.39%	-0.86%	14.12%	-1.57%	0.79%	5.87%	0.21%
FCF per Share	0.50	0.70	0.10	1.42	-0.80	-0.17	0.83	0.95
FCF Conversion (FCF/Net Income)	1.75x	1.48x	3.75x	3.19x	-6.76x	1.36x	2.47x	1.74x
Interest Paid	0	0	156K	1.12M	1.45M	3.03M	5.01M	6.52M
Taxes Paid	0	0	120K	7.87M	2.62M	99K	841K	7.35M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	16.47%	25.05%	3.73%	18.28%	2.5%	5.54%	9.87%	9.86%
Return on Invested Capital (ROIC)	19.29%	24.73%	1.81%	3.44%	0.8%	2.09%	4.11%	5.55%
Gross Margin	12.91%	14.84%	13.18%	14.04%	11.05%	12.38%	12.3%	13.49%
Net Margin	3.93%	5.48%	0.75%	4.03%	0.61%	1.4%	2.46%	3.24%
Debt / Equity	-	-	4.71x	3.15x	3.11x	2.60x	2.27x	0.88x
Interest Coverage	-	-	13.83x	15.27x	2.42x	3.34x	4.25x	5.48x
FCF Conversion	1.75x	1.48x	3.75x	3.19x	-6.76x	1.36x	2.47x	1.74x
Revenue Growth	-	13.97%	18.34%	15.49%	12.47%	7.63%	15.14%	27.59%

Revenue by Segment

	2019	2020	2021	2022	2023	2024
Home Health And Hospice Services	206.62M	253.66M	309.57M	342.25M	394.46M	515.34M
Home Health And Hospice Services Growth	-	22.76%	22.04%	10.56%	15.26%	30.64%
Senior Living Services	131.91M	137.29M	130.12M	130.99M	150.43M	175.76M
Senior Living Services Growth	-	4.08%	-5.22%	0.67%	14.84%	16.84%

Frequently Asked Questions

Valuation & Price

The Pennant Group, Inc. (PNTG) has a price-to-earnings (P/E) ratio of 42.1x. This suggests investors expect higher future growth.

Growth & Financials

The Pennant Group, Inc. (PNTG) reported $847.3M in revenue for fiscal year 2024. This represents a 238% increase from $251.0M in 2017.

The Pennant Group, Inc. (PNTG) grew revenue by 27.6% over the past year. This is strong growth.

Yes, The Pennant Group, Inc. (PNTG) is profitable, generating $26.7M in net income for fiscal year 2024 (3.2% net margin).

Dividend & Returns

The Pennant Group, Inc. (PNTG) has a return on equity (ROE) of 9.9%. This is below average, suggesting room for improvement.

The Pennant Group, Inc. (PNTG) generated $36.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.